[Ganglioblocking and curariform properties of haloidmethylates 1-(omega-dialkylaminoalykyl)-3-benzylquinuclidine hallogenoids].
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D002415:Cats; D005143:Eyelids / Q000187:drug effects; D005730:Ganglionic Blockers / Q000494:pharmacology*; D006219:Halogens / Q000494:pharmacology*; D051379:Mice; D009025:Morpholines / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology; D011812:Quinuclidines / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D009435:Synaptic Transmission / Q000187:drug effects; D014630:Vagus Nerve / Q000187:drug effects
D000959:Antihypertensive Agents; D005730:Ganglionic Blockers; D006219:Halogens; D009025:Morpholines; D011759:Pyrrolidines; D011812:Quinuclidines
Ganglioblokiruiushchie i kurarepodobnye svoĭstva galoidmetilatov 1-(omega-dialkilaminoalkil)- 3-benzilkhinuklidiniĭgalogenidov.